MicrobeWorld App

appsquarebannerad200x200

ASM Fellowships

Fellowship

Microbes After Hours

Watter-Supply-200x200-Banner

Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email

subscribe

Featured Image

Featured Video

Ebola Virus explained

Supporters

ASM House 200X200

Preterm Infants May Need a Boost to Protect Against Invasitve Pneumococcal Disease

A new study suggests that preterm infants may not be fully protected against invasitve pneumococcal disease under the current United Kingdom immunization schedule.

The findings are reported in the November issue of the journal Clinical and Vaccine Immunology.

The study, conducted by researchers from Newcastle University, began with a survey of UK neonatal intensive care units. The survey found that preterm infants at increased risk of invasive pneumococcal disease were not being adequately immunized because of a lack of evidance that these infants are protected by the pneumococcal conjugate vaccine.

Preterm babies have significantly less maternally derived antibody than full-term infants. Early effective immunization is therefore especially important to decrease the chances of pneumococcal infection.

"Our study found that in addition to a poor response to serotype 6B, perterm infants had a diminished response to serotype 23F, and several infants remained unprotected to at least one serotype following a booster dose of the vaccine," says Samantha Moss, an author of the report. "These results support the need for a booster dose in the second year of life."
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use